Method

Ascertaining the 24 Hours Residual Inactivation Efficacy of the Chemical Composition of Legionella-X Viral Off (Fortified with Silver Nanoparticles) Against Bacteria and Enveloped Viruses (Coronavirus, SARS, MERS and Influenza) After Impregnation of Surgical Masks Using JIS L 1902:2015 Test Method

Authors:
To read the file of this research, you can request a copy directly from the authors.

Abstract

Due to the SARS, MERS, Covid-19 and Influenza-A Epidemics, the medical staff and frontline staff of the public sectors are exposed to the all types of viruses. Facial masks are used as the first line of defense to shield the frontline staff against said viruses. Researchers from the Magna Think Tank Group feel that all facial masks and gowns can be further enhanced if they are impregnated with Legionella-X Viral Off Hospital Grade Disinfectant fortified with Aqueous Colloidal Silver Nanoparticles to decimate any bacteria and viruses that landed on facial masks. This article covers the mechanism and the Test Method of JIS L 1902: 2015 [1,2,3] used to ascertain the antibacterial and antimicrobial inactivation residual efficacies of Legionella-X Hospital Grade Disinfectant fortified with 2 Colloidal Silver Nanoparticles at 24 hours after impregnation into surgical masks and gowns made from both hydrophilic and hydrophobic materials.

No file available

Request Full-text Paper PDF

To read the file of this research,
you can request a copy directly from the authors.

... Porous surfaces like money, hair, and cloth fabric do not allow viruses to survive as long because the small spaces or holes in them can trap the virus and prevent its transfer. According to research the Covid-19 Virus typically lasts on common surfaces such as Glass -5 days, Wood -4 days, Copper-4 hours, Aluminium-2-8 hours, Plastic & stainless-steel -3 days, Cardboard -24 hours, ceramics examples dishes, pottery and mugs 5 days [26,27,28,29,30,31,32]. See predicter of decay of the Corvid-19 virus in Chart 1 below. ...
Article
The Coronavirus is primarily a respiratory illness, and it typically spreads via airborne droplets from an infected person's coughs or sneezes [1][2][3][4][5][6][7]. Viral particles can survive for a time on surfaces, but the coronavirus life span on surfaces depends on variables like temperature and humidity [8][9][10][11]. Early research has demonstrated that the virus's survival depends on the type of surface it lands on. The Coronavirus virus can survive anywhere between three hours and seven days, depending on the material [12][13][14][15][16][17]. A healthy person can then unknowingly touch those inanimate surfaces, people's hands can transport the viral particles to different surfaces, even the face, where it can enter your body through your eyes, mouth or nose [18
Article
Full-text available
Multidrug resistance of the pathogenic microorganisms to the antimicrobial drugs has become a major impediment toward successful diagnosis and management of infectious diseases. Recent advancements in nanotechnology-based medicines have opened new horizons for combating multidrug resistance in microorganisms. In particular, the use of silver nanoparticles (AgNPs) as a potent antibacterial agent has received much attention. The most critical physico-chemical parameters that affect the antimicrobial potential of AgNPs include size, shape, surface charge, concentration and colloidal state. AgNPs exhibits their antimicrobial potential through multifaceted mechanisms. AgNPs adhesion to microbial cells, penetration inside the cells, ROS and free radical generation, and modulation of microbial signal transduction pathways have been recognized as the most prominent modes of antimicrobial action. On the other side, AgNPs exposure to human cells induces cytotoxicity, genotoxicity, and inflammatory response in human cells in a cell-type dependent manner. This has raised concerns regarding use of AgNPs in therapeutics and drug delivery. We have summarized the emerging endeavors that address current challenges in relation to safe use of AgNPs in therapeutics and drug delivery platforms. Based on research done so far, we believe that AgNPs can be engineered so as to increase their efficacy, stability, specificity, biosafety and biocompatibility. In this regard, three perspectives research directions have been suggested that include (1) synthesizing AgNPs with controlled physico-chemical properties, (2) examining microbial development of resistance toward AgNPs, and (3) ascertaining the susceptibility of cytoxicity, genotoxicity, and inflammatory response to human cells upon AgNPs exposure.
Article
Full-text available
Silver nanoparticles are nanoparticles of silver which are in the range of 1 and 100 nm in size. Silver nanoparticles have unique properties which help in molecular diagnostics, in therapies, as well as in devices that are used in several medical procedures. The major methods used for silver nanoparticle synthesis are the physical and chemical methods. The problem with the chemical and physical methods is that the synthesis is expensive and can also have toxic substances absorbed onto them. To overcome this, the biological method provides a feasible alternative. The major biological systems involved in this are bacteria, fungi, and plant extracts. The major applications of silver nanoparticles in the medical field include diagnostic applications and therapeutic applications. In most of the therapeutic applications, it is the antimicrobial property that is being majorly explored, though the anti-inflammatory property has its fair share of applications. Though silver nanoparticles are rampantly used in many medical procedures and devices as well as in various biological fields, they have their drawbacks due to nanotoxicity. This review provides a comprehensive view on the mechanism of action, production, applications in the medical field, and the health and environmental concerns that are allegedly caused due to these nanoparticles. The focus is on effective and efficient synthesis of silver nanoparticles while exploring their various prospective applications besides trying to understand the current scenario in the debates on the toxicity concerns these nanoparticles pose.
Article
Full-text available
A number of virologic and environmental factors are involved in the emergence and re-emergence of viral disease. Viruses do not conservatively occupy a single and permanent ecological niche. Rather, due to their intrinsic capacity for genetic change, and to the evolvability of fitness levels, viruses display a potential to parasitize alternative host species. Mutation, recombination and genome segment reassortment, and combination of these molecular events, produce complex and phenotypically diverse populations of viruses, which constitute the raw material on which selection acts. The majority of emerging viral diseases of humans have a zoonotic origin. Sociologic and ecologic factors produce diverse and changing environments in which viral subpopulations have ample opportunities to be selected from intrinsically heterogeneous viral populations, particularly in the case of RNA viruses. In this manner, new human, animal and plant viruses have emerged periodically and, from all evidence, will continue to emerge. This article reviews some of the mechanisms that have been identified in viral emergence, with a focus on the importance of genetic variation of viruses, and on the general concept of biological complexity.
Article
The entry of viruses into target cells involves a complex series of sequential steps, with opportunities for inhibition at every stage. Entry inhibitors exert their biological properties by inhibiting protein-protein interactions either within the viral envelope (Env) glycoproteins or between viral Env and host-cell receptors. The nature of resistance to entry inhibitors also differs from compounds inhibiting enzymatic targets due to their different modes of action and the relative variability in Env sequences both temporally and between patients. Two drugs that target HIV-1 entry, enfuvirtide and maraviroc, are now licensed for treatment of HIV-1 infection. The efficacy of these drugs validates entry as a point of intervention in viral life cycles and, in the context of HIV treatment, contributes to the growing armamentarium of antivirals which, in multidrug combinations, can effectively inhibit viral replication and prevent disease progression.
Severe Acute Respiratory Syndrome, is an infection of the respiratory system that can be fatal in some cases. Learn to spot the signs and symptoms of SARS and ways to prevent the spread of the disease
  • Or Sars
SARS, or Severe Acute Respiratory Syndrome, is an infection of the respiratory system that can be fatal in some cases. Learn to spot the signs and symptoms of SARS and ways to prevent the spread of the disease. https://www.healthhub.sg/a-z/diseases-and-conditions/126/topic_sars
Virology" Fifth Edition: Virus Entry and Uncoating
  • A Helenius
  • Fields
Helenius A. Fields "Virology" Fifth Edition: Virus Entry and Uncoating. LWW; London, UK: 2007. pp. 99-118. [Google Scholar]
Virus entry: Molecular mechanisms and biomedical applications
  • D S Dimitrov
Dimitrov D.S. Virus entry: Molecular mechanisms and biomedical applications. Nat. Rev. 2004;2:109-120. doi: 10.1038/nrmicro817. [PubMed] [CrossRef] [Google Scholar]
Magnificently Natural www.magnachem.com.sg › legionellax Legionella-X is an innovative proprietary chemical solution that has been used in various forms against airborne and surface bacteria with remarkable 99
  • X -Magna Legionella
Legionella-X -Magna -Magnificently Natural www.magnachem.com.sg › legionellax Legionella-X is an innovative proprietary chemical solution that has been used in various forms against airborne and surface bacteria with remarkable 99.9999%
Antiviral drug resistance: mechanisms and clinical implications
  • Lynne Strasfeld
  • Sunwen Chou
Strasfeld, Lynne, and Sunwen Chou. "Antiviral drug resistance: mechanisms and clinical implications." Infectious disease clinics of North America vol. 24,2 (2010): 413-37. doi:10.1016/j.idc.2010.01.001
Bioinformatics Prediction of Interaction Silver Nanoparticles on the Disulfide Bonds of HIV-1 Gp120 Protein
Bioinformatics Prediction of Interaction Silver Nanoparticles on the Disulfide Bonds of HIV-1 Gp120 Protein. International Journal of Scientific Research in Knowledge. 2. 67-74. 10.12983/ijsrk-2014-p0067-0074.
Honorary Doctorate) is the founder and chairman of Magna Group, consisting of Magna International
  • Nelson Cheng
Nelson Cheng PhD (Honorary Doctorate) is the founder and chairman of Magna Group, consisting of Magna International;
Winner of the Global Star, Asia Star and Singapore Star Packaging Awards
Asia Packaging Award, Top 10 Most Inspiring Entrepreneur 2015, Winner of the Global Star, Asia Star and Singapore Star Packaging Awards 2014, 2015, 2016, 2017, 2014, Top Entrepreneur Award-Singapore Small Medium Business Association, Asia Excellence Award 2014 and Top 20 Innovation Award 2013 from Small Medium Business Association.
Moe is the senior technical manager of Magna International Pte. Ltd. He has a BSc in Industrial Chemistry
  • Patrick Patrick Moe
Patrick Moe Patrick Moe is the senior technical manager of Magna International Pte. Ltd. He has a BSc in Industrial Chemistry, Grad. Dip and MSc in Environmental Engineering.